Global Mesenchymal Stem Cells Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

Description

List of Tables

The global demand for Mesenchymal Stem Cells Market is presumed to reach the market size of nearly USD 22.77 BN by 2030 from USD 7.08 BN in 2022 with a CAGR of 15.72% under the study period 2023 - 2030.

Mesenchymal stem cells (MSCs) are a type of stem cell found in various tissues in the body, including bone marrow, adipose tissue, and umbilical cord tissue. These cells can differentiate into a variety of cell types, including bone cells, cartilage cells, and fat cells. MSCs have a number of potential therapeutic applications due to their ability to differentiate into various cell types and secrete growth factors and other biologically active molecules.

Market Dynamics:

The increasing demand for regenerative medicine and its unique properties may contribute to the growth of the MSCs market. Moreover, MSCs have been shown to have anti-inflammatory effects and modulate the immune system, which makes them a potential therapeutic option for chronic inflammation conditions. Furthermore, the increasing demand for regenerative medicine may contribute to the market's growth. However, the limited availability of mesenchymal stem cells for use in research and clinical treatments may limit the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of mesenchymal stem cells. The growth and trends of mesenchymal stem cells industry provide a holistic approach to this study.

Market Segmentation:

This section of the mesenchymal stem cells market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Services

Products (Workflow Type, Product Type)
Services

By Type

Autologous
Allogeneic

By Source Of Isolation

Bone Marrow
Cord Blood
Peripheral Blood
Fallopian Tube
Fetal Liver
Lung
Adipose Tissues

By Indication

Bone And Cartilage Repair
Cardiovascular Disease
Inflammatory And Immunological Diseases
Liver Diseases
Cancer
GvHD
Others

By Application

Disease Modelling
Drug Development & Discovery
Stem Cell Banking
Tissue Engineering
Toxicology Studies
Others

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Mesenchymal Stem Cells market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the mesenchymal stem cells market include Thermo Fisher Scientific Inc., Cell Applications Inc., Axol Biosciences Ltd., Cytori Therapeutics Inc, STEMCELL Technologies Inc, Cyagen Biosciences Inc., Celprogen Inc, BrainStorm Cell Therapeutics Inc., Stemedica Cell Technologies Inc, Merck KGaA (MilliporeSigma), Smith+Nephew, Lonza AG, PromoCell GmbH, ScienCell Research Laboratories, American Type Culture Collection. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

Product Code: VMR11219961

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . MESENCHYMAL STEM CELLS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product & Services
- 3.7.2 Market Attractiveness Analysis By Type
- 3.7.3 Market Attractiveness Analysis By Source Of Isolation
- 3.7.4 Market Attractiveness Analysis By Indication
- 3.7.5 Market Attractiveness Analysis By Application
- 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL MESENCHYMAL STEM CELLS MARKET ANALYSIS BY PRODUCT & SERVICES

6.1 Overview by Product & Services
6.2 Historical and Forecast Data
6.3 Analysis by Product & Services
6.4 Products (Workflow Type, Product Type) Historic and Forecast Sales by Regions
6.5 Services Historic and Forecast Sales by Regions

7 . GLOBAL MESENCHYMAL STEM CELLS MARKET ANALYSIS BY TYPE

7.1 Overview by Type
7.2 Historical and Forecast Data
7.3 Analysis by Type
7.4 Autologous Historic and Forecast Sales by Regions
7.5 Allogeneic Historic and Forecast Sales by Regions

8 . GLOBAL MESENCHYMAL STEM CELLS MARKET ANALYSIS BY SOURCE OF ISOLATION

8.1 Overview by Source Of Isolation
8.2 Historical and Forecast Data
8.3 Analysis by Source Of Isolation
8.4 Bone Marrow Historic and Forecast Sales by Regions
8.5 Cord Blood Historic and Forecast Sales by Regions
8.6 Peripheral Blood Historic and Forecast Sales by Regions
8.7 Fallopian Tube Historic and Forecast Sales by Regions
8.8 Fetal Liver Historic and Forecast Sales by Regions
8.9 Lung Historic and Forecast Sales by Regions
8.10. Adipose Tissues Historic and Forecast Sales by Regions

9 . GLOBAL MESENCHYMAL STEM CELLS MARKET ANALYSIS BY INDICATION

9.1 Overview by Indication
9.2 Historical and Forecast Data
9.3 Analysis by Indication
9.4 Bone And Cartilage Repair Historic and Forecast Sales by Regions
9.5 Cardiovascular Disease Historic and Forecast Sales by Regions
9.6 Inflammatory And Immunological Diseases Historic and Forecast Sales by Regions
9.7 Liver Diseases Historic and Forecast Sales by Regions
9.8 Cancer Historic and Forecast Sales by Regions
9.9 GvHD Historic and Forecast Sales by Regions
9.10. Others Historic and Forecast Sales by Regions

10 . GLOBAL MESENCHYMAL STEM CELLS MARKET ANALYSIS BY APPLICATION

10.1 Overview by Application
10.2 Historical and Forecast Data
10.3 Analysis by Application
10.4 Disease Modelling Historic and Forecast Sales by Regions
10.5 Drug Development & Discovery Historic and Forecast Sales by Regions
10.6 Stem Cell Banking Historic and Forecast Sales by Regions
10.7 Tissue Engineering Historic and Forecast Sales by Regions
10.8 Toxicology Studies Historic and Forecast Sales by Regions
10.9 Others Historic and Forecast Sales by Regions

11 . GLOBAL MESENCHYMAL STEM CELLS MARKET ANALYSIS BY GEOGRAPHY

11.1. Top Company Share Analysis
11.2. Introduction
11.3. North America Sales Analysis
- 11.3.1. Overview, Historic and Forecast Sales Analysis
- 11.3.2. North America By Segment Sales Analysis
- 11.3.3. North America By Country Sales Analysis
- 11.3.4. United State Sales Analysis
- 11.3.5. Canada Sales Analysis
- 11.3.6. Mexico Sales Analysis
11.4. Europe Sales Analysis
- 11.4.1. Overview, Historic and Forecast Sales Analysis
- 11.4.2. Europe by Segment Sales Analysis
- 11.4.3. Europe by Country Sales Analysis
- 11.4.4. United Kingdom Sales Analysis
- 11.4.5. France Sales Analysis
- 11.4.6. Germany Sales Analysis
- 11.4.7. Italy Sales Analysis
- 11.4.8. Russia Sales Analysis
- 11.4.9. Rest Of Europe Sales Analysis
11.5. Asia Pacific Sales Analysis
- 11.5.1. Overview, Historic and Forecast Sales Analysis
- 11.5.2. Asia Pacific by Segment Sales Analysis
- 11.5.3. Asia Pacific by Country Sales Analysis
- 11.5.4. China Sales Analysis
- 11.5.5. India Sales Analysis
- 11.5.6. Japan Sales Analysis
- 11.5.7. South Korea Sales Analysis
- 11.5.8. Australia Sales Analysis
- 11.5.9. Rest Of Asia Pacific Sales Analysis
11.6. Latin America Sales Analysis
- 11.6.1. Overview, Historic and Forecast Sales Analysis
- 11.6.2. Latin America by Segment Sales Analysis
- 11.6.3. Latin America by Country Sales Analysis
- 11.6.4. Brazil Sales Analysis
- 11.6.5. Argentina Sales Analysis
- 11.6.6. Peru Sales Analysis
- 11.6.7. Chile Sales Analysis
- 11.6.8. Rest of Latin America Sales Analysis
11.7. Middle East & Africa Sales Analysis
- 11.7.1. Overview, Historic and Forecast Sales Analysis
- 11.7.2. Middle East & Africa by Segment Sales Analysis
- 11.7.3. Middle East & Africa by Country Sales Analysis
- 11.7.4. Saudi Arabia Sales Analysis
- 11.7.5. UAE Sales Analysis
- 11.7.6. Israel Sales Analysis
- 11.7.7. South Africa Sales Analysis
- 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE MESENCHYMAL STEM CELLS COMPANIES

12.1. Mesenchymal Stem Cells Market Competition
12.2. Partnership/Collaboration/Agreement
12.3. Merger And Acquisitions
12.4. New Product Launch
12.5. Other Developments

13 . COMPANY PROFILES OF MESENCHYMAL STEM CELLS INDUSTRY

13.1. Company Share Analysis
13.2. Market Concentration Rate
13.3. Thermo Fisher Scientific Inc.
- 13.3.1. Company Overview
- 13.3.2. Company Revenue
- 13.3.3. Products
- 13.3.4. Recent Developments
13.4. Cell Applications Inc.
- 13.4.1. Company Overview
- 13.4.2. Company Revenue
- 13.4.3. Products
- 13.4.4. Recent Developments
13.5. Axol Biosciences Ltd.
- 13.5.1. Company Overview
- 13.5.2. Company Revenue
- 13.5.3. Products
- 13.5.4. Recent Developments
13.6. Cytori Therapeutics Inc
- 13.6.1. Company Overview
- 13.6.2. Company Revenue
- 13.6.3. Products
- 13.6.4. Recent Developments
13.7. STEMCELL Technologies Inc
- 13.7.1. Company Overview
- 13.7.2. Company Revenue
- 13.7.3. Products
- 13.7.4. Recent Developments
13.8. Cyagen Biosciences Inc.
- 13.8.1. Company Overview
- 13.8.2. Company Revenue
- 13.8.3. Products
- 13.8.4. Recent Developments
13.9. Celprogen Inc
- 13.9.1. Company Overview
- 13.9.2. Company Revenue
- 13.9.3. Products
- 13.9.4. Recent Developments
13.10. BrainStorm Cell Therapeutics Inc.
- 13.10.1. Company Overview
- 13.10.2. Company Revenue
- 13.10.3. Products
- 13.10.4. Recent Developments
13.11. Stemedica Cell Technologies Inc
- 13.11.1. Company Overview
- 13.11.2. Company Revenue
- 13.11.3. Products
- 13.11.4. Recent Developments
13.12. Merck KGaA (MilliporeSigma)
- 13.12.1. Company Overview
- 13.12.2. Company Revenue
- 13.12.3. Products
- 13.12.4. Recent Developments
13.13. Smith+Nephew
- 13.13.1. Company Overview
- 13.13.2. Company Revenue
- 13.13.3. Products
- 13.13.4. Recent Developments
13.14. Lonza AG
- 13.14.1. Company Overview
- 13.14.2. Company Revenue
- 13.14.3. Products
- 13.14.4. Recent Developments
13.15. PromoCell GmbH
- 13.15.1. Company Overview
- 13.15.2. Company Revenue
- 13.15.3. Products
- 13.15.4. Recent Developments
13.16. ScienCell Research Laboratories
- 13.16.1. Company Overview
- 13.16.2. Company Revenue
- 13.16.3. Products
- 13.16.4. Recent Developments
13.17. American Type Culture Collection
- 13.17.1. Company Overview
- 13.17.2. Company Revenue
- 13.17.3. Products
- 13.17.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies